The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...

Severe hypertriglyceridemia may also represent more rare, under-lying genetic dyslipidemias, such as LPL deficiency [15] or homozygous apolipoprotein C-II (apoC-II) deficiency, [16] which occur in ...

Sobi® (STO: SOBI) and Ionis Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...